BR0209103A - Omeprazol forma c, processo para preparação e uso do mesmo e formulação farmacêutica - Google Patents

Omeprazol forma c, processo para preparação e uso do mesmo e formulação farmacêutica

Info

Publication number
BR0209103A
BR0209103A BR0209103-8A BR0209103A BR0209103A BR 0209103 A BR0209103 A BR 0209103A BR 0209103 A BR0209103 A BR 0209103A BR 0209103 A BR0209103 A BR 0209103A
Authority
BR
Brazil
Prior art keywords
omeprazole
preparation
pharmaceutical formulation
omeprazole form
methoxy
Prior art date
Application number
BR0209103-8A
Other languages
English (en)
Inventor
Milae Natasa Hafner
Anton Opar
Barbara Podobnik
Beleie Andreja Cizerle
Alenka Kosak
Brina Ornik
Uros Urleb
Original Assignee
Lek Tovarna Farmacevtskih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20432882&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0209103(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lek Tovarna Farmacevtskih filed Critical Lek Tovarna Farmacevtskih
Publication of BR0209103A publication Critical patent/BR0209103A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"OMEPRAZOL FORMA C, PROCESSO PARA PREPARAçãO E USO DO MESMO E FORMULAçãO FARMACêUTICA". é revelada uma forma cristalina inovadora da substância conhecida pelo nome químico de 5-metoxi-2-[[(4-metoxi-3,5-dimetil-2-piridinil)metil]sulfinil]-1H-benzimida zol, e tendo o nome genérico omeprazol, referido a seguir como omeprazol forma C. Adicionalmente, são revelados: um processo para a preparação de omeprazol forma C, uma formulação farmacêutica contendo omeprazol forma C em mistura com excipientes aceitáveis na forma farmacêutica, e o uso de omeprazol forma C para tratamento de distúrbios gastrintestinais.
BR0209103-8A 2001-04-25 2002-04-24 Omeprazol forma c, processo para preparação e uso do mesmo e formulação farmacêutica BR0209103A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200100111A SI20875A (sl) 2001-04-25 2001-04-25 Kristalna oblika omeprazola
PCT/IB2002/001350 WO2002085889A1 (en) 2001-04-25 2002-04-24 Crystalline form of omeprazole

Publications (1)

Publication Number Publication Date
BR0209103A true BR0209103A (pt) 2004-07-13

Family

ID=20432882

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0209103-8A BR0209103A (pt) 2001-04-25 2002-04-24 Omeprazol forma c, processo para preparação e uso do mesmo e formulação farmacêutica

Country Status (26)

Country Link
US (2) US20040122056A1 (pt)
EP (1) EP1390360B1 (pt)
JP (1) JP4455815B2 (pt)
KR (1) KR20030094358A (pt)
CN (1) CN1531533B (pt)
AT (1) ATE346063T1 (pt)
AU (1) AU2002307892B2 (pt)
BG (1) BG108287A (pt)
BR (1) BR0209103A (pt)
CA (1) CA2445251C (pt)
CZ (1) CZ20032911A3 (pt)
DE (1) DE60216273T2 (pt)
HR (1) HRP20030853B1 (pt)
HU (1) HUP0303928A2 (pt)
IL (1) IL158561A0 (pt)
MX (1) MXPA03009789A (pt)
NO (1) NO20034715L (pt)
NZ (1) NZ528917A (pt)
PL (1) PL366471A1 (pt)
RS (1) RS50880B (pt)
RU (1) RU2286991C2 (pt)
SI (2) SI20875A (pt)
SK (1) SK13192003A3 (pt)
UA (1) UA77671C2 (pt)
WO (1) WO2002085889A1 (pt)
ZA (1) ZA200307988B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
EP1904064A4 (en) * 2005-07-07 2009-12-02 Reddys Lab Ltd Dr OMEPRAZOLE OF FORM B
PL1988163T3 (pl) * 2006-02-22 2012-11-30 Int Inst Cancer Immunology Inc Ograniczony do hla-a*3303 peptyd wt1 i zawierająca go kompozycja farmaceutyczna
CA2665226C (en) 2006-10-05 2014-05-13 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2486910A3 (en) 2006-10-27 2012-08-22 The Curators Of The University Of Missouri Multi-chambered apparatus comprising a dispenser head
EP2114919A2 (en) 2007-01-31 2009-11-11 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic seperation
WO2010134099A1 (en) 2009-05-21 2010-11-25 Cadila Healthcare Limited One pot process for preparing omeprazole and related compounds
CN102786513A (zh) * 2011-05-18 2012-11-21 中国医学科学院药物研究所 奥美拉唑晶e型物质及制备方法与在药品和保健品中应用
CN102351846B (zh) * 2011-09-07 2012-08-22 周晓东 一种新的奥美拉唑钠化合物及其药物组合物
KR101459088B1 (ko) * 2012-08-02 2014-12-02 대화제약 주식회사 알-라베프라졸, 이의 금속염의 제조방법
EP4426694A1 (en) * 2021-11-05 2024-09-11 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrochloride salt of linaprazan glurate
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
ES2078447T3 (es) * 1990-06-15 1995-12-16 Merck & Co Inc Un procedimiento de cristalizacion para mejorar la estructura y el tamaño de los cristales.
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SI20019A (sl) * 1998-07-13 2000-02-29 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
US6166213A (en) * 1998-08-11 2000-12-26 Merck & Co., Inc. Omeprazole process and compositions thereof
UA72748C2 (en) * 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
AUPQ841800A0 (en) * 2000-06-28 2000-07-20 Biomolecular Research Institute Limited Truncated egf receptor
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs

Also Published As

Publication number Publication date
YU84003A (sh) 2006-08-17
EP1390360B1 (en) 2006-11-22
ATE346063T1 (de) 2006-12-15
NO20034715L (no) 2003-12-10
RU2003133213A (ru) 2005-05-10
UA77671C2 (en) 2007-01-15
SI1390360T1 (sl) 2007-04-30
JP4455815B2 (ja) 2010-04-21
US7553856B2 (en) 2009-06-30
NZ528917A (en) 2006-02-24
EP1390360A1 (en) 2004-02-25
HRP20030853A2 (en) 2005-08-31
PL366471A1 (en) 2005-02-07
MXPA03009789A (es) 2005-03-07
US20040122056A1 (en) 2004-06-24
CA2445251A1 (en) 2002-10-31
DE60216273T2 (de) 2007-05-31
HRP20030853B1 (en) 2011-11-30
CN1531533B (zh) 2012-07-18
JP2004526786A (ja) 2004-09-02
BG108287A (bg) 2005-04-30
RS50880B (sr) 2010-08-31
CN1531533A (zh) 2004-09-22
NO20034715D0 (no) 2003-10-21
US20060079560A1 (en) 2006-04-13
CZ20032911A3 (en) 2004-06-16
RU2286991C2 (ru) 2006-11-10
WO2002085889A1 (en) 2002-10-31
DE60216273D1 (de) 2007-01-04
AU2002307892B2 (en) 2008-04-17
IL158561A0 (en) 2004-05-12
HUP0303928A2 (hu) 2004-03-01
SI20875A (sl) 2002-10-31
KR20030094358A (ko) 2003-12-11
ZA200307988B (en) 2004-10-14
SK13192003A3 (sk) 2004-03-02
CA2445251C (en) 2011-01-04

Similar Documents

Publication Publication Date Title
BR0209103A (pt) Omeprazol forma c, processo para preparação e uso do mesmo e formulação farmacêutica
ES2191944T3 (es) Forma cristalina de la sal de sodio de omeprazol.
BR9816067A (pt) Forma a de omeprazol, omeprazol, processo para a preparação da forma a de omeprazol, formulação farmacêutica, uso de omeprazol, e, método de tratamento de distúrbios gastrointestinais.
CL2009000805A1 (es) Composicion farmaceutica que comprende a una sal sodica del enantiomero (-) de 5-metoxi-2[[(4-metoxi-3,5-dimetil-2-piridinil)metil]sulfinil]-1h-bencimidazol ((-)-omeprazol); y su uso en la inhibicion de la secrecion de acido gastrico y para tratar enfermedades inflamatorias gastrointestinales. (divisional solicitud 3570-00).
AR010361A1 (es) "S-OMEPRAZOL [ENANTIoMERO S DE 5-METOXI-2-[[(4--METOXI-3,5-DIMETIL-2-PIRIDINIL)-METIL]SULFINIL]-1H-BENCIMIDAZOL], EN UNA FORMA NEUTRA NO SALINA, PROCESO PARA SU PREPARACION, COMPOSICION FARMACEUTICA, Y SU USO PARA LA MANUFACTURA DE MEDICAMENTOS"
BR0007647A (pt) Sal de potássio de forma b de (s) -omeprazol, processo para a preparação do mesmo, formulação farmacêutica, uso do sal de potássio da forma b de (s) -omeprazol, e, método de tratamento de distúrbios gastrointestinais
ATE284861T1 (de) N-aralkylaminotetraline als neuropeptid-y-y5- rezeptorliganden
BR9806157A (pt) Composições farmacêuticas de descarboetoxiloratadina anidras, não higroscópicas e sem lactose
JP2002535401A5 (pt)
ATE386725T1 (de) Heterocyclylverbindungen
AR013740A1 (es) Proceso para la preparacion de omeprazol, compuesto y formulacion farmaceutica del mismo
ATE110379T1 (de) Therapeutisch aktive substituierte benzimidazole und verfahren zu ihrer herstellung.
PT1242061E (pt) Utilizacao de metabolitos bioactivos de gepirona para o fabrico de um medicamento para o tratamento de desordens psicologicas
NO20021337L (no) 4-benzylaminokinolinkonjugater med gallesyre og deres heteroanaloger, fremgangsmåte for deres fremstilling, legemidlerinneholdende disse forbindelser og deres anvendelse
JP2007504222A5 (pt)
AR016700A1 (es) Omeprazol forma a cristalina. proceso para su preparacion, formulaciones farmaceuticas que lo contienen, y uso del mismo
IT1271434B (it) Composizione farmaceutica avente attivita' antiasmatica
UY26420A1 (es) Procedimiento mejorado para la preparación de derivados bencimidazol adecuados como fármacos antiulcerosos, particularmente omeprazol o pantoprazol
YU32301A (sh) Novi kristalni oblik omeprazola

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 11, 13, 24 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]